Drug intelligence / Profile preview

german chamomile extract

Development stage
Phase 3
Lead developer
Viatris
Modality
Small Molecules
Administration
Oral, Topical, Ophthalmic, Rectal, Inhalation
01

Overview

German chamomile extract, derived from the flowers of *Matricaria chamomilla*, is a complex botanical preparation utilized for its therapeutic anxiolytic, anti-inflammatory, and spasmolytic effects. Its pharmacodynamic profile is driven by several key bioactive constituents, most notably the flavonoid apigenin and the sesquiterpenes chamazulene and α-bisabolol. Apigenin functions as a ligand for central benzodiazepine receptors, acting as a positive allosteric modulator of the GABA-A receptor to induce mild sedation and reduce anxiety without the significant side effects associated with synthetic benzodiazepines. Additionally, the extract exhibits potent anti-inflammatory properties by inhibiting the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) pathways, which reduces the synthesis of pro-inflammatory prostaglandins and leukotrienes. It is widely applied in both clinical and traditional settings for the treatment of generalized anxiety disorder, gastrointestinal spasms, and various inflammatory conditions of the skin and mucous membranes.

Brand names
KamillosanChamomilla Curarina
Other names
Matricaria recutita extractMatricaria chamomilla extractWild chamomile extract
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)GABRR (GABA-A receptor subunit rho)ALOX5 (Arachidonate 5-lipoxygenase)

Beyond the preview

Go deeper on german chamomile extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on german chamomile extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call